Sobi has successfully completed the issuance of class C shares, securing its long-term commitments and positioning the company for potential future growth.
Sysmex Corp, a Japanese healthcare equipment company, is well-positioned for long-term success despite current challenges, driven by growing demand for its products in the in-vitro diagnostics market.
Smith & Nephew PLC’s stock price has reached a 12-month high following an analyst upgrade and a director’s purchase of shares, indicating confidence in the company’s future prospects.
AstraZeneca has seen a significant decrease in short interest, a drop in bearish sentiment, as the company invests in expanding its US production capacity and participates in a consortium to enhance Sweden’s competitiveness in artificial intelligenc…
Fisher & Paykel Healthcare Corp Ltd has reported a strong financial performance for the first half of 2026, with a 13% increase in operating revenue and a 31% rise in net profit after tax.
Sonic Healthcare Ltd has released its financial report for the year ended 30 June 2025, showing a 0.4% increase in revenue and moderate growth in statutory profit after tax.
Vertex Pharmaceuticals will participate in several investor conferences, including the 2025 Wells Fargo Healthcare Conference, to increase investor interest and confidence in the company.
Dexcom’s stock stagnation is a warning sign that the company’s dominance in the diabetes monitoring market may be threatened by emerging competition and a need for innovation.